Clinical Trials Directory

Trials / Completed

CompletedNCT06292156

tACS Treatment for Cognitive Impairments in Methamphetamine Addicts

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Beijing HuiLongGuan Hospital · Academic / Other
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

1. To evaluate the cognitive function of methamphetamine Patients. 2. Investigate the pathological mechanism of methamphetamine patients from the aspects of EEG and biology; 3. The investigators investigated the effects of transcranial alternating current stimulation (tACS) on cognitive impairments in methamphetamine patients

Conditions

Interventions

TypeNameDescription
DEVICETheta treatment groupThe target 'active' electrode was placed over the MFC and the second 'return' electrode was placed over the medial parietal cortex. 6 Hz stimulation was used and a alternating current of 2mA was applied for 30min each day(Monday-Friday) for 3consecutive weeks
DEVICESham control groupSham stimulation lasted 30 s (15 s of ramp- up and 15 s of ramp-down).

Timeline

Start date
2023-12-30
Primary completion
2024-12-30
Completion
2024-12-30
First posted
2024-03-04
Last updated
2025-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06292156. Inclusion in this directory is not an endorsement.